JP2001354558A5 - - Google Patents

Download PDF

Info

Publication number
JP2001354558A5
JP2001354558A5 JP2000174803A JP2000174803A JP2001354558A5 JP 2001354558 A5 JP2001354558 A5 JP 2001354558A5 JP 2000174803 A JP2000174803 A JP 2000174803A JP 2000174803 A JP2000174803 A JP 2000174803A JP 2001354558 A5 JP2001354558 A5 JP 2001354558A5
Authority
JP
Japan
Prior art keywords
monoacylglycerol
fatty acids
weight
constituent fatty
agent
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2000174803A
Other languages
English (en)
Japanese (ja)
Other versions
JP2001354558A (ja
JP5226912B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority to JP2000174803A priority Critical patent/JP5226912B2/ja
Priority claimed from JP2000174803A external-priority patent/JP5226912B2/ja
Publication of JP2001354558A publication Critical patent/JP2001354558A/ja
Publication of JP2001354558A5 publication Critical patent/JP2001354558A5/ja
Application granted granted Critical
Publication of JP5226912B2 publication Critical patent/JP5226912B2/ja
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

JP2000174803A 2000-06-12 2000-06-12 Ｐｐａｒ活性化剤 Expired - Fee Related JP5226912B2 (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2000174803A JP5226912B2 (ja) 2000-06-12 2000-06-12 Ｐｐａｒ活性化剤

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2000174803A JP5226912B2 (ja) 2000-06-12 2000-06-12 Ｐｐａｒ活性化剤

Publications (3)

Publication Number Publication Date
JP2001354558A JP2001354558A (ja) 2001-12-25
JP2001354558A5 true JP2001354558A5 (enExample) 2008-02-28
JP5226912B2 JP5226912B2 (ja) 2013-07-03

Family

ID=18676772

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2000174803A Expired - Fee Related JP5226912B2 (ja) 2000-06-12 2000-06-12 Ｐｐａｒ活性化剤

Country Status (1)

Country Link
JP (1) JP5226912B2 (enExample)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPWO2002102364A1 (ja) * 2001-06-18 2004-09-30 山田　幸子 ＰＰＡＲγ作動性医薬組成物
CN1870983B (zh) 2002-02-14 2010-12-01 麒麟麦酒株式会社 用于改善脂质代谢的组合物和食品
FR2850869B1 (fr) * 2003-02-12 2005-03-25 Genfit S A Utilisations d'aminopropanediols acyles et de leurs analogues azotes et sulfures
DE10314078A1 (de) 2003-03-28 2004-10-14 Nutrinova Nutrition Specialties & Food Ingredients Gmbh Verfahren zur Aufreinigung von Verbindungen mit funktionellen Gruppen
JP4634065B2 (ja) * 2004-05-14 2011-02-16 花王株式会社 アディポネクチン低下抑制剤
JP4972336B2 (ja) * 2006-04-24 2012-07-11 花王株式会社 Ｇｉｐ分泌抑制剤
JP4878494B2 (ja) * 2006-04-24 2012-02-15 花王株式会社 食後血中インスリン上昇抑制剤
JP5798281B2 (ja) * 2006-09-27 2015-10-21 株式会社セラバリューズ ＰＰＡＲγ活性化剤
JPWO2008084864A1 (ja) * 2007-01-11 2010-05-06 日清ファルマ株式会社 カプサイシン受容体活性化剤及びそれを噴霧する装置
JP5385572B2 (ja) * 2007-09-28 2014-01-08 出光興産株式会社 Ｐｐａｒ結合作用剤
EP2445494A4 (en) * 2009-06-24 2012-12-12 Univ Koebenhavn TREATMENT OF INSULIN RESISTANCE AND OBESITY BY STIMULATING GLP-1 RELEASE
JP2010241832A (ja) * 2010-07-20 2010-10-28 Kao Corp アディポネクチン低下抑制剤
JP2012171911A (ja) 2011-02-22 2012-09-10 Kao Corp Ｐｐａｒ活性化剤
JP2012171924A (ja) * 2011-02-22 2012-09-10 Kao Corp Ｐｐａｒ活性化剤

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL64542A0 (en) 1981-12-15 1982-03-31 Yissum Res Dev Co Long-chain alpha,omega-dicarboxylic acids and derivatives thereof and pharmaceutical compositions containing them
JP3098560B2 (ja) * 1991-03-28 2000-10-16 花王株式会社 体重増加抑制剤
JP3098561B2 (ja) * 1991-03-28 2000-10-16 花王株式会社 血清トリグリセリド濃度低下剤
JP2969234B2 (ja) * 1991-07-19 1999-11-02 株式会社アドバンス Ａｃａｔ阻害剤
JPH05310567A (ja) * 1992-05-07 1993-11-22 Kao Corp 血清トリグリセリド濃度低下剤
AU718500B2 (en) 1997-01-23 2000-04-13 Sumitomo Pharmaceuticals Company, Limited Remedies for diabetes
JP3607062B2 (ja) * 1997-10-24 2005-01-05 株式会社コーセー 脂肪蓄積抑制剤及びそれを含有する皮膚外用剤
CA2313626A1 (en) * 1997-12-12 1999-06-17 Purdue Research Foundation Methods and compositions for treating diabetes
JP2000355538A (ja) * 1999-04-15 2000-12-26 Kanegafuchi Chem Ind Co Ltd ペルオキシゾーム活性化剤応答性受容体アゴニスト
JP4139544B2 (ja) * 2000-03-06 2008-08-27 花王株式会社 血糖値低下剤
JP2001247473A (ja) * 2000-03-06 2001-09-11 Kao Corp インスリン抵抗性改善剤

Similar Documents

Publication Publication Date Title
JP2001354558A5 (enExample)
DE60037726D1 (de) Carbonsäurederivate die die bindung von integrinen an ihre rezeptoren hemmen
CA2161191A1 (fr) Produit pour application topique contenant une lipase et un precurseur d'actif
ID26221A (id) Komposisi-komposisi farmasi yang dapat dijadikan gel
PT1152755E (pt) Acidos gordos essenciais destinados a prevencao de acidentes cardio-vasculares
EP1226104A4 (en) PHENOXY CARBOXYLIC ACID COMPOUNDS AND COMPOSITIONS USED TO DIFFUSER ACTIVE AGENTS
EP1702597A3 (en) Drug delivery of phase changing formulation
EP2289521A3 (en) Compositions and methods for use in tergeting vascular destruction
JP2006520801A5 (enExample)
JP2002518502A5 (enExample)
ZA200000169B (en) Process for the preparation of pellets with a content of up to 90 wt.% of a pharmaceutical active ingredient.
TNSN99135A1 (fr) Composition neuroprotectrice pour la prevention et/ou le traitement des troubles nerveux ou de comportement dus aux etats d'anxiete ou de depression
ATE277923T1 (de) Propansäurederivate, die die bindung von integrinen an ihre rezeptoren behindern
BR0013958A (pt) Dieta de elevado teor de lipìdios
AU4862796A (en) Formulations of compounds as nanoparticulate dispersions in digestible oils or fatty acids
UY26303A1 (es) Composiciones farmacéuticas para administración oral y tópica
CA2383140A1 (en) Ppar.alpha. and ppar.gamma. inhibitors
EP0955047A3 (en) Use of conjugated linoleic acids to modify platelet function
PL351323A1 (en) Inhibitors of lfa−1 binding to icams and uses thereof
JP2002520286A5 (enExample)
FR2754177B1 (fr) Microspheres pharmaceutiques d'acide valproique pour administration orale
JP2005513014A5 (enExample)
WO2003018064A3 (en) Lipophilic drug compositions
EP1219288A3 (en) Treatment for skin
FR2843124B1 (fr) Procede de preparation d'acides gras polyinsatures libres et de leurs metabolites d'oxydation